BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 22863800)

  • 1. Mucoadhesive tablets for controlled release of acyclovir.
    Ruiz-Caro R; Gago-Guillan M; Otero-Espinar FJ; Veiga MD
    Chem Pharm Bull (Tokyo); 2012; 60(10):1249-57. PubMed ID: 22863800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation.
    Dhaliwal S; Jain S; Singh HP; Tiwary AK
    AAPS J; 2008 Jun; 10(2):322-30. PubMed ID: 18523891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of mucoadhesive floating hollow beads of acyclovir with gastroretentive properties.
    Svirskis D; Seyfoddin A; Chalabi S; In Kim JH; Langford C; Painter S; Al-Kassas R
    Pharm Dev Technol; 2014 Aug; 19(5):571-6. PubMed ID: 23859639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of acyclovir oral tablets based on gastroretention technology: factorial design analysis and physicochemical characterization studies.
    El Gamal SS; Naggar VF; Allam AN
    Drug Dev Ind Pharm; 2011 Jul; 37(7):855-67. PubMed ID: 21401342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix tablets: the effect of hydroxypropyl methylcellulose/anhydrous dibasic calcium phosphate ratio on the release rate of a water-soluble drug through the gastrointestinal tract I. In vitro tests.
    Mamani PL; Ruiz-Caro R; Veiga MD
    AAPS PharmSciTech; 2012 Dec; 13(4):1073-83. PubMed ID: 22907778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-layered mucoadhesive tablets containing nystatin.
    Llabot JM; Manzo RH; Allemandi DA
    AAPS PharmSciTech; 2002; 3(3):E22. PubMed ID: 12916937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of gastroretentive floating tablets of acyclovir.
    Garg R; Gupta GD
    Curr Drug Deliv; 2009 Oct; 6(5):437-43. PubMed ID: 19751200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on vaginal bioadhesive tablets of acyclovir.
    Genç L; Oğuzlar C; Güler E
    Pharmazie; 2000 Apr; 55(4):297-9. PubMed ID: 10798244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Hydrophilic Polymers on the Release Rate and Pharmacokinetics of Acyclovir Tablets Obtained by Wet Granulation: In Vitro and In Vivo Assays.
    Venkatesh DN; Meyyanathan SN; Kovacevic A; Zielińska A; Fonseca J; Eder P; Dobrowolska A; Souto EB
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of a monolithic floating drug delivery system for acyclovir.
    Tavakoli N; Varshosaz J; Dorkoosh F; Motaghi S; Tamaddon L
    Chem Pharm Bull (Tokyo); 2012; 60(2):172-7. PubMed ID: 22293475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysozyme Mucoadhesive Tablets Obtained by Freeze-Drying.
    Gennari CGM; Sperandeo P; Polissi A; Minghetti P; Cilurzo F
    J Pharm Sci; 2019 Nov; 108(11):3667-3674. PubMed ID: 31446146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastroretentive mucoadhesive tablet of lafutidine for controlled release and enhanced bioavailability.
    Patil S; Talele GS
    Drug Deliv; 2015 May; 22(3):312-9. PubMed ID: 24471787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral sustained delivery of atenolol from floating matrix tablets-formulation and in vitro evaluation.
    Srivastava AK; Wadhwa S; Ridhurkar D; Mishra B
    Drug Dev Ind Pharm; 2005 May; 31(4-5):367-74. PubMed ID: 16093202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrageenan-Based Acyclovir Mucoadhesive Vaginal Tablets for Prevention of Genital Herpes.
    Pacheco-Quito EM; Ruiz-Caro R; Rubio J; Tamayo A; Veiga MD
    Mar Drugs; 2020 May; 18(5):. PubMed ID: 32403219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of HPMC - E15 LV premium polymer on release profile and compression characteristics of chitosan/ pectin colon targeted mesalamine matrix tablets and in vitro study on effect of pH impact on the drug release profile.
    Newton AM; Lakshmanan P
    Recent Pat Drug Deliv Formul; 2014 Apr; 8(1):46-62. PubMed ID: 24597626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained release of acetaminophen from a heterogeneous mixture of two hydrophilic non-ionic cellulose ether polymers.
    Ebube NK; Jones AB
    Int J Pharm; 2004 Mar; 272(1-2):19-27. PubMed ID: 15019065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between the viscoelastic properties of the gel layer of swollen HPMC matrix tablets and their in vitro drug release.
    Hamed R; Al Baraghthi T; Sunoqrot S
    Pharm Dev Technol; 2018 Nov; 23(9):838-848. PubMed ID: 27808590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gum Ghatti--a pharmaceutical excipient: development, evaluation and optimization of sustained release mucoadhesive matrix tablets of domperidone.
    Gurpreetarora ; Malik K; Rana V; Singh I
    Acta Pol Pharm; 2012; 69(4):725-37. PubMed ID: 22876617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.